Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis

Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis

Ginseng, the root and rhizome of Panax ginseng C. A. Mey., is a famous herbal medicine, and its major ginsenosides exert beneficial effects on nonalcoholic fatty liver disease (NAFLD). Due to the multicomponent and multitarget features of ginsenosides, their detailed mechanisms remain unclear. This...

Full description

Bibliographic Details
Main Authors:	Wenyi Liang, Kun Zhou, Ping Jian, Zihao Chang, Qiunan Zhang, Yuqi Liu, Shuiming Xiao, Lanzhen Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Pharmacology
Subjects:	ginsenosides nonalcoholic fatty liver disease network pharmacology gut microbiota inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.622841/full

Similar Items

Prebiotics enhance the biotransformation and bioavailability of ginsenosides in rats by modulating gut microbiota
by: Xiaoyan Zhang, et al.
Published: (2021-03-01)

Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications
by: Tongxi Zhuang, et al.
Published: (2021-08-01)

Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease
by: Yuzhen Zhao, et al.
Published: (2019-12-01)

Gut microbiota in obesity and nonalcoholic fatty liver disease
by: Lina Guo, et al.
Published: (2021-06-01)

Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis
by: Fuxi Li, et al.
Published: (2021-02-01)

The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease
by: Kouichi Miura, et al.
Published: (2017-06-01)

Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function
by: Ji Taek Hong, et al.
Published: (2021-03-01)

Effects of gut microbiota on the pharmacokinetics of protopanaxadiol ginsenosides Rd, Rg3, F2, and compound K in healthy volunteers treated orally with red ginseng
by: Jeon-Kyung Kim, et al.
Published: (2020-07-01)

Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan
by: Ming-Chao Tsai, et al.
Published: (2020-03-01)

Gut microbiota and nonalcoholic fatty liver disease
by: Mariana V. Machado, et al.
Published: (2012-07-01)

Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
by: Chien-Chao Chiu, et al.
Published: (2017-11-01)

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
by: Na Fei, et al.
Published: (2020-02-01)

Gut microbiota and nonalcoholic fatty liver disease
by: XIAO Li, et al.
Published: (2017-04-01)

The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target
by: Takaomi Kessoku, et al.
Published: (2021-07-01)

Bioconversion variation of ginsenoside CK mediated by human gut microbiota from healthy volunteers and colorectal cancer patients
by: Yin-Ping Guo, et al.
Published: (2021-03-01)

The Role of the Gut Microbiome and its Derived Mediators in Nonalcoholic Fatty Liver Disease
by: Cosmas Rinaldi A. Lesmana, et al.
Published: (2019-12-01)

Bifidobacteria-Fermented Red Ginseng and Its Constituents Ginsenoside Rd and Protopanaxatriol Alleviate Anxiety/Depression in Mice by the Amelioration of Gut Dysbiosis
by: Sang-Kap Han, et al.
Published: (2020-03-01)

Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE−/− mice
by: Yunci Ma, et al.
Published: (2019-05-01)

Impact of SchisandraChinensis Bee Pollen on Nonalcoholic Fatty Liver Disease and Gut Microbiota in HighFat Diet Induced Obese Mice
by: Ni Cheng, et al.
Published: (2019-02-01)

Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease
by: Jiake Yu, et al.
Published: (2021-09-01)

Da-Chai-Hu Decoction Ameliorates High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Remodeling the Gut Microbiota and Modulating the Serum Metabolism
by: Huantian Cui, et al.
Published: (2020-11-01)

Ginsenoside Rb1, salvianolic acid B and their combination modulate gut microbiota and improve glucolipid metabolism in high-fat diet induced obese mice
by: Ying Bai, et al.
Published: (2021-02-01)

The Gut Microbiota, Tumorigenesis, and Liver Diseases
by: Guishuai Lv, et al.
Published: (2017-02-01)

The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
by: Marco Sanduzzi Zamparelli, et al.
Published: (2016-07-01)

Intestinal Lactobacillus species improve immune enhancement by ginsenoside Rb1 and ginsenoside Rb1 increases intestinal Akkermansia proportions
by: Miseon Sung, et al.
Published: (2021-11-01)

Consumption of Wild Rice (<i>Zizania latifolia</i>) Prevents Metabolic Associated Fatty Liver Disease through the Modulation of the Gut Microbiota in Mice Model
by: Xiao-Dong Hou, et al.
Published: (2020-07-01)

Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy
by: Junli Ma, et al.
Published: (2017-10-01)

The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease
by: Silvia M. Ferolla, et al.
Published: (2014-12-01)

The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies
by: Marica Meroni, et al.
Published: (2019-11-01)

Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics
by: Xuyun He, et al.
Published: (2016-03-01)

Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice
by: Ying Hong, et al.
Published: (2021-01-01)

Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
by: Xiao-Fang Yang, et al.
Published: (2021-07-01)

Gut Microbiota and Inflammation
by: Goran Molin, et al.
Published: (2011-06-01)

Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis
by: Silvia M. Ferolla, et al.
Published: (2016-06-01)

Detrimental Impact of Microbiota-Accessible Carbohydrate-Deprived Diet on Gut and Immune Homeostasis: An Overview
by: Claire Immediato Daïen, et al.
Published: (2017-05-01)

<i>Momordica cochinchinensis</i> Aril Ameliorates Diet-Induced Metabolic Dysfunction and Non-Alcoholic Fatty Liver by Modulating Gut Microbiota
by: Hsiu-Chen Huang, et al.
Published: (2021-03-01)

Gut Microbiota and Host Reaction in Liver Diseases
by: Hiroshi Fukui
Published: (2015-10-01)

Commensal Homeostasis of Gut Microbiota-Host for the Impact of Obesity
by: Pengyi Zhang, et al.
Published: (2018-01-01)

Research progress in roles of gut microbiota and bile acid metabolism in development and progression of NAFLD
by: LU Xu
Published: (2014-11-01)

New Insights of OLFM2 and OLFM4 in Gut‐Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
by: Aguilar, C., et al.
Published: (2022)